23andMe, a consumer gene test company, faced a significant drop in share price leading to potential privatization. CEO Anne Wojcicki, holding a substantial stake in the company, considers taking it private to avert collapse.
23andMe CEO Anne Wojcicki is moving to take the company private. https://t.co/DDACoqaf5G
23andMe co-founder and CEO Anne Wojcicki holds more than 20% of outstanding stock in the company and 49.9% of its voting stock. https://t.co/TVlPQR2EMu
23andMe CEO Anne Wojcicki Considers Taking Company Private https://t.co/miJsl1aEEb
Money-losing 23andMe might get taken private. The consumer gene test company did an IPO-by-SPAC in 2021. Stock buyers got cleaned out by a ~95% drop in share price as market concluded the company is worth around zero. https://t.co/HZSGgMUZOB
23andMe Saved From Collapse After CEO Floats Private Takeover https://t.co/7WF1dmWirs